Glenmede Trust’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$333K Sell
31,760
-1,222
-4% -$12.8K ﹤0.01% 1045
2024
Q4
$399K Sell
32,982
-4,956
-13% -$60K ﹤0.01% 1012
2024
Q3
$557K Sell
37,938
-240
-0.6% -$3.53K ﹤0.01% 901
2024
Q2
$551K Sell
38,178
-6,737
-15% -$97.2K ﹤0.01% 874
2024
Q1
$731K Sell
44,915
-4,187
-9% -$68.2K ﹤0.01% 801
2023
Q4
$732K Sell
49,102
-73,196
-60% -$1.09M ﹤0.01% 786
2023
Q3
$1.37M Sell
122,298
-167,764
-58% -$1.89M 0.01% 588
2023
Q2
$2.73M Hold
290,062
0.02% 473
2023
Q1
$2.73M Buy
290,062
+162,224
+127% +$1.52M 0.02% 474
2022
Q4
$1.56M Sell
127,838
-191,397
-60% -$2.34M 0.01% 569
2022
Q3
$3.96M Sell
319,235
-394,508
-55% -$4.89M 0.03% 416
2022
Q2
$14M Sell
713,743
-82,765
-10% -$1.62M 0.08% 270
2022
Q1
$20.8M Sell
796,508
-8,403
-1% -$219K 0.1% 233
2021
Q4
$22.8M Sell
804,911
-27,941
-3% -$793K 0.11% 221
2021
Q3
$26.6M Sell
832,852
-2,714
-0.3% -$86.5K 0.14% 178
2021
Q2
$29M Buy
835,566
+3,233
+0.4% +$112K 0.15% 170
2021
Q1
$24.5M Buy
832,333
+26,593
+3% +$783K 0.13% 181
2020
Q4
$24.7M Buy
805,740
+3,756
+0.5% +$115K 0.14% 186
2020
Q3
$22.4M Buy
801,984
+127,038
+19% +$3.55M 0.13% 178
2020
Q2
$14.5M Sell
674,946
-132,777
-16% -$2.85M 0.09% 264
2020
Q1
$23.8M Hold
807,723
0.11% 254
2019
Q4
$23.8M Sell
807,723
-267,703
-25% -$7.88M 0.11% 254
2019
Q3
$28.6K Sell
1,075,426
-17,780
-2% -$473 0.13% 211
2019
Q2
$36.9K Buy
1,093,206
+510,967
+88% +$17.3K 0.16% 174
2019
Q1
$18.7K Buy
+582,239
New +$18.7K 0.08% 310